C5 and chlamydia trachomatis infectious disease: These discoveries illuminate the mechanism of a C3-independent C5 activation induced by chlamydial infection, and furthermore provide a potential therapeutic target and drug for preventing tubal fibrosis caused by chlamydial infection.